For example, biotech Biogen developed Aduhelm (aducanumab), a monoclonal antibody therapy for Alzheimer's disease.
Beyond oncology, mAbs have found applications in autoimmune diseases, infectious diseases, and even neurological disorders. For example, biotech Biogen developed Aduhelm (aducanumab), a monoclonal antibody therapy for Alzheimer's disease. While its 2021 approval generated significant controversy, it serves as a testament to the power of biotechnology in addressing complex medical conditions.